Protocolo de manejo de pacientes con enfermedad pulmonar obstructiva crónica tras agudización en urgencias(Pag.- e 101998)

  1. L. Ginel Mendoza 1
  2. J. Gonzálvez Rey 2
  3. J.A. Trigueros Carrero 3
  4. P. Piñera Salmerón 4
  1. 1 Centro de Salud Ciudad Jardín, Málaga, España
  2. 2 Centro de Salud Teis, Vigo, España
  3. 3 Centro de Salud Buenavista, Toledo, España
  4. 4 Hospital General Universitario Reina Sofía, Murcia, España
Mostrar afiliacións +
Revista:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Ano de publicación: 2023

Número: 6

Páxinas: 7-7

Tipo: Artigo

DOI: 10.1016/J.SEMERG.2023.101998 DIALNET GOOGLE SCHOLAR

Outras publicacións en: Semergen: revista española de medicina de familia

Obxectivos de Desenvolvemento Sustentable

Resumo

In chronic obstructive pulmonary disease, an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is an episode of clinical instability due to the worsening of expiratory airflow limitation or of the underlying inflammatory process. The severity of AECOPD depends on baseline risk stratification and the intensity of the acute episode. Primary Care is the epicenter of the AECOPD care circuit, but it can be extended to the out-of-hospital emergency department and the hospital itself depending on the clinical situation, the level of severity, the availability of complementary tests, and the therapeutic resources required for each patient. Recording clinical data, history, triggering factors, treatment, and evolution of previous episodes of AECOPD in the electronic medical record is an essential aspect to adjust current treatment and prevent the occurrence of future episodes.

€ Ver financiamento

Información de financiamento

Financiadores

Referencias bibliográficas

  • A. Calderón Montero Cardiopulmonary axis and cardiovascular mortality in patients with COPD Semergen., 49 (2023), p. 101928, 10.1016/j.semerg.2023.101928 View PDFView articleView in ScopusGoogle Scholar
  • J.B. Soriano, I. Alfageme, M. Miravitlles, P. de Lucas, J.J. Soler-Cataluña, F. García-Río, et al. Prevalence and determinants of COPD in Spain: EPISCAN II Arch Bronconeumol (Engl Ed)., 57 (2021), pp. 61-69, 10.1016/j.arbres.2020.07.024 View PDFView articleGoogle Scholar
  • P. Sobradillo Ecenarro, J.L. García-Rivero, J.C. López Caro El tratamiento broncodilatador en la prevención de las exacerbaciones de la EPOC Semergen., 45 (2019), pp. 479-488, 10.1016/j.semerg.2019.03.009 View PDFView articleView in ScopusGoogle Scholar
  • J.J. Soler-Cataluña, P. Piñera, J.A. Trigueros, M. Calle, C. Casanova, B.G. Cosío, et al. Spanish COPD Guidelines (GesEPOC) 2021 update diagnosis and treatment of COPD exacerbation syndrome Arch Bronconeumol., 58 (2022), pp. 159-170, 10.1016/j.arbres.2021.05.011 View PDFView articleView in ScopusGoogle Scholar
  • M. MacLeod, A. Papi, M. Contoli, B. Beghé, B.R. Celli, J.A. Wedzicha, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact Respirology., 26 (2021), pp. 532-551, 10.1111/resp.14041 View PDF This article is free to access. View in ScopusGoogle Scholar
  • J.J. Soler-Cataluña, M.A. Martínez-García, P. Román Sánchez, E. Salcedo, M. Navarro, R. Ochando Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease Thorax., 60 (2005), pp. 925-931, 10.1136/thx.2005.040527 View article View in ScopusGoogle Scholar
  • A.L. Aguilar-Shea, C. Gallardo-Mayo Revisión narrativa de la terapia inhalatoria en la EPOC Semergen., 48 (2022), pp. 214-218, 10.1016/j.semerg.2021.08.001 View PDFView articleView in ScopusGoogle Scholar
  • M.R.C. Crutsen, S.J. Keene, D.J.A.J.N. Nakken, M.T. Groenen, S.M.J. van Kuijk, F.M.E. Franssen, et al. Physical, psychological, and social factors associated with exacerbation-related hospitalization in patients with COPD J Clin Med, 9 (2020), p. 636, 10.3390/jcm9030636 View article View in ScopusGoogle Scholar
  • S.H. Jeong, H. Lee, K.C. Carriere, S.H. Shin, S.M. Moon, B.H. Jeong, et al. Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients Int J Chron Obstruct Pulmon Dis., 11 (2016), pp. 1857-1865, 10.2147/COPD.S103063 View article View in ScopusGoogle Scholar
  • G.C. Donaldson, T.A. Seemungal, I.S. Patel, S.J. Lloyd-Owen, T.M. Wilkinson, J.A. Wedzicha Longitudinal changes in the nature, severity and frequency of COPD exacerbations Eur Respir J., 22 (2003), pp. 931-936, 10.1183/09031936.03.00038303 View article View in ScopusGoogle Scholar
  • K. Chen, K.A. Pleasants, R.A. Pleasants, T. Beiko, R.G. Washburn, Z. Yu, et al. A systematic review and meta-analysis of sputum purulence to predict bacterial infection in COPD exacerbations COPD., 17 (2020), pp. 311-317, 10.1080/15412555.2020.1766433 View PDF This article is free to access. View in ScopusGoogle Scholar
  • J.C. Bestall, E.A. Paul, R. Garrod, R. Garnham, P.W. Jones, J.A. Wedzicha Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease Thorax., 54 (1999), pp. 581-586, 10.1136/thx.54.7.581 View article View in ScopusGoogle Scholar
  • D.A. Mahler, D.H. Weinberg, C.K. Wells, A.R. Feinstein The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes Chest., 85 (1984), pp. 751-758, 10.1378/chest.85.6.751 View PDFView articleView in ScopusGoogle Scholar
  • M.J. Mador, T.J. Kufel Reproducibility of visual analog scale measurements of dyspnea in patients with chronic obstructive pulmonary disease Am Rev Respir Dis., 146 (1992), pp. 82-87, 10.1164/ajrccm/146.1.82 View article View in ScopusGoogle Scholar
  • K. Puteikis, R. Mameniskiene, E. Jureviciene Neurological and psychiatric comorbidities in chronic ostructive pulmonary disease Int J Chron Obstruct Pulmon Dis., 16 (2021), pp. 553-562 View PDF This article is free to access. CrossRefView in ScopusGoogle Scholar
  • P.A. Jacobsen, K. Kragholm, C. Torp-Pedersen, U. Moller Weinreich Disability retirement after first admission with acute exacerbatin of chronic obstructive pulmonary disease: A Danish nationwide registry cohort study using a refrospective follow-up design Int J Chron Obstruct Pulmon Dis., 17 (2022), pp. 2541-2551 View PDF This article is free to access. CrossRefView in ScopusGoogle Scholar
  • V. Plaza, C. Fernández-Rodríguez, C. Melero, B.G. Cosío, L.M. Entrenas, L.P. de Llano, et al. Validation of the’Test of the Adherence to Inhalers’ (TAI) for asthma and COPD patients J Aerosol Med Pulm Drug Deliv., 29 (2016), pp. 142-152, 10.1089/jamp.2015.1212 View article View in ScopusGoogle Scholar
  • X. Flor-Escriche, A. Sanz Bas, S. Álvarez Álvarez, V. Zamora Putin, M. Monteagudo Zaragoza, Grupo del estudio MUNBA Riesgos, fenotipos y comparación de tratamiento de EPOC en atención primaria según guías GOLD y GesEPOC Semergen., 48 (2022), p. 101839, 10.1016/j.semerg.2022.101839 View PDFView articleView in ScopusGoogle Scholar
  • J.J. Soler Cataluña, A. Fernández Villar, M. Román Rodríguez, J. Ancochea Bermúdez Proceso asistencial integrado del paciente con EPOC exacerbado (PACEX-EPOC) Respira-Fundación Española del Pulmón-SEPAR, Barcelona (2015) Google Scholar
  • M. Miravitlles, M. Calle, J. Molina, P. Almagro, J.T. Gómez, J.A. Trigueros, et al. Spanish COPD Guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD Arch Bronconeumol., 58 (2022), pp. 69-81, 10.1016/j.arbres.2021.03.005 View PDFView articleView in ScopusGoogle Scholar
  • N.R. Anthonisen, J. Manfreda, C.P. Warren, E.S. Hershfield, G.K. Harding, N.A. Nelson Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease Ann Intern Med., 106 (1987), pp. 196-204, 10.7326/0003-4819-106-2-196 View article View in ScopusGoogle Scholar
  • J.D. Leuppi, P. Schuetz, R. Bingisser, M. Bodmer, M. Briel, T. Drescher, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: The REDUCE randomized clinical trial JAMA., 309 (2013), pp. 2223-2231, 10.1001/jama.2013.5023 View PDF This article is free to access. View in ScopusGoogle Scholar
  • B. Alcázar Navarrete, J. Ancochea Bermúdez, F. García-Río, J.L. Izquierdo Alonso, M. Miravitlles, J.M. Rodríguez González-Moro, et al. Patients with chronic obstructive pulmonary disease exacerbations: Recommendations for diagnosis, treatment and care Arch Bronconeumol (Engl Ed)., 55 (2019), pp. 478-487, 10.1016/j.arbres.2019.02.020 View PDFView articleView in ScopusGoogle Scholar
  • J.L. Izquierdo, J.M. Rodríguez, C. Almonacid, M. Benavent, R. Arroyo-Espliguero, A. Agustí Real-life burden of hospitalisations due to COPD exacerbations in Spain ERJ Open Res., 8 (2022), 10.1183/23120541.00141-2022 00141-2022 View article Google Scholar
  • C.W. Kong, T.M.A. Wilkinson Predicting and preventing hospital readmission for exacerbations of COPD ERJ Open Res., 6 (2020), 10.1183/23120541.00325-2019 00325-2019 View article Google Scholar
  • N. Gupta, L.M. Pinto, A. Morogan, J. Bourbeau The COPD assessment test: A systematic review Eur Respir J., 44 (2014), pp. 873-884, 10.1183/09031936.00025214 View article View in ScopusGoogle Scholar
  • K. Huh, Y.E. Kim, W. Ji, D.W. Kim, E.J. Lee, J.H. Kim, et al. Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: A nationwide claims study Thorax., 76 (2021), pp. 939-941, 10.1136/thoraxjnl-2020-216526 View article View in ScopusGoogle Scholar
  • M.A. Alsallakh, S. Sivakumaran, S. Kennedy, E. Vasileiou, R.A. Lyons, C. Robertson, et al. Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: National interrupted time series analyses for Scotland and Wales BMC Med., 19 (2021), p. 124, 10.1186/s12916-021-02000-w View PDF This article is free to access. View in ScopusGoogle Scholar
  • F.B. Ahmad, R.N. Anderson The leading causes of death in the US for 2020 JAMA., 325 (2021), pp. 1829-1830, 10.1001/jama.2021.5469 View PDF This article is free to access. View in ScopusGoogle Scholar
Fonte de datos: Dialnet